Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00217880 · ClinicalTrials.gov registry record · NA
Significance of Biological Markers in Patients With Acute Lung Injury/Acute Respiratory Disease
A NA study of Respiratory Distress Syndrome, Adult, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 2
- Study locations
NCT00217880: Completed NA study of Respiratory Distress Syndrome, Adult, sponsored by University of Michigan.
NCT00217880 is a NA study of Respiratory Distress Syndrome, Adult that has completed, run by University of Michigan. The registered enrollment target is 40 participants, below the 321-participant average among 7 other Respiratory Distress Syndrome, Adult trials with a reported enrollment target (88% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00217880, a NA study of Respiratory Distress Syndrome, Adult, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to identify biological markers of disease in patients with acute lung injury (ALI) that are predictive of either disease susceptibility or prognosis, or that identify novel targets of therapeutic intervention.
Conditions Studied
Interventions
- PROCEDURE Bronchoscopy
Study Locations (2)
Georgia
- Emory University - Atlanta
Michigan
- University of Michigan - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2004-07 |
| Est. Completion | 2009-06 |
| Phase | NA |
What the finished NCT00217880 record still lists
NCT00217880 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 321-participant average among 7 other Respiratory Distress Syndrome, Adult trials with a reported enrollment target (88% lower).
The record links to 1 condition, with Respiratory Distress Syndrome, Adult appearing as the primary indexed condition, and to 1 intervention - of which Bronchoscopy is the first listed.
NCT00217880 reports a single indexed study location in Georgia, Michigan.
Frequently Asked Questions
What is clinical trial NCT00217880 about?
NCT00217880 is a clinical study titled "Significance of Biological Markers in Patients With Acute Lung Injury/Acute Respiratory Disease". The purpose of this study is to identify biological markers of disease in patients with acute lung injury (ALI) that are predictive of either disease susceptibility or prognosis, or that identify novel targets of therapeutic intervention.
What is the current status of trial NCT00217880?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2004-07. Estimated completion is 2009-06.
What conditions does trial NCT00217880 study?
This clinical trial studies the following conditions: Respiratory Distress Syndrome, Adult.
What interventions are being tested in trial NCT00217880?
The interventions under investigation include: Bronchoscopy (PROCEDURE).
Who is sponsoring clinical trial NCT00217880?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00217880 being conducted?
This trial has 2 study locations across Georgia, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Respiratory Distress Syndrome, Adult
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Trial of Therapeutic Hypothermia in Patients With ARDS
RECRUITING · Phase 2
-
Long Term Follow up of Children Enrolled in the REDvent Study
ACTIVE NOT RECRUITING
-
Phase I Study of Vasoactive Intestinal Peptide in Patients With Acute Respiratory Distress Syndrome and Sepsis
COMPLETED · Phase 1
-
Identifying PARDS Endotypes
COMPLETED
-
Early Versus Delayed Enteral Feeding to Treat People With Acute Lung Injury or Acute Respiratory Distress Syndrome (The EDEN Study)
COMPLETED · Phase 3
-
Carbon Monoxide to Prevent Lung Inflammation
COMPLETED · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia